Cargando…
BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study
Background: Neuroblastoma (N.B.) is the most common tumor in children. The gene BDP1 (B Double Prime 1) plays a role in cancers but is less known in N.B. Thus, we conducted this study to investigate the value of BDP1 mutations in N.B. prognosis. Methods: A dataset of 121 NB patients from the Cancer...
Autores principales: | Li, Xiaoqing, Sun, Lan, Stucky, Andres, Tu, Lingli, Cai, Jin, Chen, Xuelian, Wu, Zhongjun, Jiang, Xuhong, Li, Shengwen Calvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700758/ https://www.ncbi.nlm.nih.gov/pubmed/34943600 http://dx.doi.org/10.3390/diagnostics11122364 |
Ejemplares similares
-
Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
por: Li, Xiaoqing, et al.
Publicado: (2022) -
Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364
por: Schramm, Laura
Publicado: (2022) -
RNA-Sequencing Combined With Genome-Wide Allele-Specific Expression
Patterning Identifies ZNF44 Variants as a Potential New Driver Gene for
Pediatric Neuroblastoma
por: Sun, Lan, et al.
Publicado: (2023) -
1264. Healthcare-Acquired Influenza in Critical Ill Patients
por: Gutierrez, Valentina, et al.
Publicado: (2018) -
BDP1 as a biomarker in serous ovarian cancer
por: Cabarcas‐Petroski, Stephanie, et al.
Publicado: (2022)